Cart
sales@molnova.com
Neoruscogenin
CAS No. 17676-33-4
Neoruscogenin( —— )
Catalog No. M18130 CAS No. 17676-33-4
Neoruscogenin represents a universal pharmacological tool for RORα research due to its specific selectivity profile versus other nuclear receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 116 | In Stock |
|
| 10MG | 197 | In Stock |
|
| 25MG | 331 | In Stock |
|
| 50MG | 482 | In Stock |
|
| 100MG | 718 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNeoruscogenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeoruscogenin represents a universal pharmacological tool for RORα research due to its specific selectivity profile versus other nuclear receptors.
-
DescriptionNeoruscogenin represents a universal pharmacological tool for RORα research due to its specific selectivity profile versus other nuclear receptors.
-
In VitroWestern Blot Analysis Cell Line:C2C12 myoblasts Concentration:0.1 μM Incubation Time:5 days Result:Increased protein expression of MyHC and MyOG at 0.1 μM, but did not work as well as 0.1 μM at 5 and 10 μM
-
In VivoAnimal Model:male ICR mice Dosage:1 mg/kg Administration:i.p.Result:Showd the larger size of TA muscles, and increasaed the weight of Gas muscles.Showed visible myofibers hypertrophy (H&E staining).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17676-33-4
-
Formula Weight428.61
-
Molecular FormulaC27H40O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (116.66 mM)
-
SMILESC[C@]12CC[C@H]([C@@](C)([C@H](O)C[C@H](O)C3)C3=CC4)[C@@H]4[C@@H]1C[C@H]5[C@@H]2[C@H](C)[C@](O5)(CC6)OCC6=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cephaeline dihydrobr...
Reference standards.
-
ML267
ML 267 is a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth.
-
Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
